Kenji Ikezawa Selected Research

Kenji Ikezawa Research Topics

Disease

10	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 12/2010
9	Neoplasms (Cancer) 05/2022 - 12/2010
4	Adenocarcinoma 04/2022 - 07/2017
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 06/2021 - 02/2014
2	Hemorrhage 04/2022 - 11/2009
2	Pulmonary Embolism 04/2022 - 01/2022
2	Neoplasms, Cystic, Mucinous, and Serous 04/2020 - 05/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2010 - 08/2007
1	Persistent Infection 05/2022
1	Virus Diseases (Viral Diseases) 05/2022
1	Hepatitis B 05/2022
1	Infections 05/2022
1	Obstructive Jaundice (Cholestatic Jaundice) 04/2022
1	Anemia 04/2022
1	Venous Thromboembolism 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Microsatellite Instability 06/2021
1	Cholangiocarcinoma 06/2021
1	Cholangitis 05/2021
1	Pathologic Complete Response 05/2021
1	Disease Progression 10/2020
1	Hepatocellular Carcinoma (Hepatoma) 04/2020
1	Thrombosis (Thrombus) 04/2020
1	Thromboembolism 04/2020
1	Sclerosing Cholangitis 07/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2019
1	Pancreatitis 01/2018
1	Synovial Sarcoma (Synovioma) 09/2016
1	Neoplasm Metastasis (Metastasis) 09/2016
1	Jaundice (Icterus) 12/2013
1	Hemobilia 12/2013
1	False Aneurysm (Pseudoaneurysm) 12/2013
1	Acute Abdomen 12/2013
1	Pneumoperitoneum 01/2012
1	Thrombocytopenia (Thrombopenia) 12/2010
1	Hemangioma (Angioma) 11/2009
1	Disseminated Intravascular Coagulation 11/2009
1	Kasabach-Merritt Syndrome 11/2009
1	Fibrosis (Cirrhosis) 08/2007

Drug/Important Bio-Agent (IBA)

5	Gemcitabine FDA Link 11/2022 - 12/2013
4	130-nm albumin-bound paclitaxelIBA 11/2022 - 06/2021
3	Polysaccharides (Glycans)IBA 01/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 08/2007
2	Leucovorin (Folinic Acid)FDA Link 11/2022 - 06/2021
2	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 06/2021
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2022 - 06/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2022 - 06/2021
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 04/2020
2	Sialyl Lewis X AntigenIBA 01/2022 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	RNA (Ribonucleic Acid)IBA 05/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2022
1	alpha-aminopyridineIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	PentosesIBA 01/2022
1	Arabinose (L-Arabinose)IBA 01/2022
1	pembrolizumabIBA 06/2021
1	Cyclin D1IBA 05/2021
1	EnzymesIBA 05/2021
1	N-acetylneuraminoyllactoseIBA 01/2021
1	N-acetyllactosamineIBA 01/2021
1	FucoseIBA 01/2021
1	Lactose FDA LinkGeneric 01/2021
1	Circulating Tumor DNAIBA 10/2020
1	Tyrosine Kinase InhibitorsIBA 04/2020
1	Sorafenib (BAY 43-9006)FDA Link 04/2020
1	regorafenibIBA 04/2020
1	lenvatinibIBA 04/2020
1	BilirubinIBA 01/2020
1	PlasticsIBA 01/2020
1	micaIBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2019
1	Bevacizumab (Avastin)FDA Link 07/2019
1	Lipase (Acid Lipase)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 09/2016
1	CyanoacrylatesIBA 12/2013
1	Protons (Proton)IBA 12/2013
1	Indicators and Reagents (Reagents)IBA 05/2011
1	danaparoid (Orgaran)FDA Link 11/2009
1	Dacarbazine (DIC)FDA LinkGeneric 11/2009
1	Branched-Chain Amino AcidsIBA 08/2007
1	ZincIBA 08/2007

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2022 - 12/2010
6	Therapeutics 04/2022 - 08/2007
2	Stents 01/2020 - 12/2013
1	Folfox protocol 11/2022
1	Immunotherapy 05/2022
1	Self Expandable Metallic Stents 04/2022
1	Erythrocyte Transfusion 04/2022
1	Conservative Treatment 04/2022
1	Duodenoscopes 04/2022
1	Surgical Instruments (Clip) 03/2022
1	Chemoradiotherapy 09/2021
1	Induction Chemotherapy 09/2021
1	Neoadjuvant Therapy 01/2020
1	Adjuvant Chemotherapy 09/2016
1	Metastasectomy 09/2016
1	Radiotherapy 12/2013
1	Decompression 01/2012